Methods | Dataset | Number of the top-ranked genes | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
2 | 3 | 4 | 5 | 6 | 7 | 8 | 20 | 40 | 60 | ||
HBSA-KNN | Leukemia (Acc) | 84.62 | 94.23 | 92.31 | 94.23 | 82.69 | 82.69 | 82.69 | 88.46 | 90.38 | 92.31 |
sensitivity | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |
specificity | 71.43 | 89.29 | 85.71 | 89.29 | 67.86 | 67.86 | 67.86 | 78.57 | 82.14 | 85.71 | |
PPV | 75 | 88.89 | 85.71 | 88.89 | 72.73 | 72.73 | 72.73 | 80 | 82.76 | 85.71 | |
NPV | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |
DLBCL (Acc) | 95.24 | 100 | 80.95 | 85.71 | 80.95 | 85.71 | 85.71 | 85.71 | 85.71 | 90.48 | |
sensitivity | 100 | 100 | 85.71 | 85.71 | 78.57 | 85.71 | 85.71 | 85.71 | 85.71 | 92.86 | |
specificity | 85.71 | 100 | 71.43 | 85.71 | 85.71 | 85.71 | 85.71 | 85.71 | 85.71 | 85.71 | |
PPV | 93.33 | 100 | 85.71 | 92.31 | 91.67 | 92.31 | 92.31 | 92.31 | 92.31 | 92.86 | |
NPV | 93.33 | 100 | 85.71 | 92.31 | 91.67 | 92.31 | 92.31 | 92.31 | 92.31 | 92.86 | |
Prostate (Acc) | 88.24 | 76.47 | 82.35 | 85.29 | 82.35 | 79.41 | 76.47 | 76.47 | 82.35 | 85.29 | |
Sensitivity | 100 | 100 | 100 | 100 | 100 | 88.89 | 88.89 | 88.89 | 88.89 | 100 | |
Specificity | 84 | 68 | 76 | 80 | 76 | 76 | 72 | 72 | 80 | 80 | |
PPV | 69.23 | 52.94 | 60 | 64.29 | 60 | 57.14 | 53.33 | 53.33 | 61.54 | 64.29 | |
NPV | 100 | 100 | 100 | 100 | 100 | 95 | 94.74 | 94.74 | 95.24 | 100 | |
SRBCT | 75 | 95 | 95 | 100 | 95 | 95 | 95 | 95 | 95 | 100 | |
ALL | 75 | 82 | 87 | 94 | 92 | 93 | 93 | 96 | 97 | 99 | |
Colon (Acc) | 65 | 70 | 80 | 75 | 80 | 80 | 75 | 75 | 75 | 75 | |
sensitivity | 75 | 83.33 | 91.67 | 91.67 | 91.67 | 83.33 | 83.33 | 83.33 | 75 | 75 | |
specificity | 50 | 50 | 62.50 | 50 | 62.50 | 75 | 62.50 | 62.50 | 75 | 75 | |
PPV | 69.23 | 71.43 | 78.57 | 73.33 | 78.57 | 83.33 | 76.92 | 76.92 | 81.82 | 81.82 | |
 | NPV | 57.14 | 66.67 | 83.33 | 80 | 83.33 | 75 | 71.43 | 71.43 | 66.67 | 66.67 |
PAM | Dataset | Number of the selected genes | |||||||||
2 | 4 | 6 | 8 | 10 | 12 | 16 | 20 | 40 | 60 | ||
Leukemia | 82.69 | 90.38 | 90.38 | 90.38 | 92.31 | 94.23 | 96.15 | 96.15 | 98.08 | 98.08 | |
DLBCL | 66.67 | 66.67 | 66.67 | 66.67 | 66.67 | 66.67 | 66.67 | 66.67 | 66.67 | 66.67 | |
Prostate | 73.53 | 73.53 | 73.53 | 73.53 | 73.53 | 73.53 | 73.53 | 73.53 | 73.53 | 73.53 | |
SRBCT | 45 | 45 | 75 | 75 | 85 | 95 | 95 | 95 | 95 | 95 | |
ALL | 43 | 61 | 61 | 68 | 68 | 83 | 85 | 85 | 86 | 86 | |
 | Colon | 65 | 75 | 70 | 70 | 70 | 75 | 75 | 75 | 75 | 75 |
ClaNC | Dataset | Number of the selected genes | |||||||||
1 ×  k * | 2 ×  k | 3 ×  k | 4 ×  k | 5 ×  k | 6 ×  k | 7 ×  k | 8 ×  k | 9 ×  k | 10 ×  k | ||
Leukemia | 86.54 | 90.39 | 90.39 | 92.31 | 90.39 | 94.23 | 94.23 | 94.23 | 94.23 | 96.15 | |
DLBCL | 80.95 | 95.24 | 95.24 | 95.24 | 95.24 | 80.95 | 76.19 | 71.43 | 71.43 | 71.43 | |
Prostate | 73.53 | 85.29 | 79.41 | 76.47 | 76.47 | 79.41 | 79.41 | 76.47 | 76.47 | 79.41 | |
SRBCT | 85 | 95 | 95 | 95 | 95 | 95 | 95 | 95 | 95 | 95 | |
ALL | 86 | 95 | 97 | 99 | 98 | 98 | 99 | 99 | 99 | 98 | |
 | Colon | 65 | 65 | 65 | 70 | 70 | 75 | 75 | 75 | 75 | 75 |